Aim/Background: Vitamin D supplementation during pregnancy is a well-accepted recommendation worldwide; however, the debate about the correct dose is ongoing. We aimed to compare daily doses of 600, 1,200, and 2,000 IU in this randomized, controlled study. Methods: The study group consisted of 91 pregnant women aged 16-42 years admitted to Kocaeli Maternity and Children Hospital between April 2011 and April 2012. The participants were randomly divided into 3 groups. 600, 1,200, and 2,000 IU/day of vitamin D was supplemented to group 1 (control group, n = 31), group 2 (n = 31), and group 3 (n = 32), respectively. Serum calcium, 25-hydroxyvitamin D (25OHD), and the calcium/creatinine ratio in spot urine samples were measured in the follow-up period. The serum calcium and 25OHD levels of the mothers' infants were measured as well. Results: The frequency of vitamin D sufficiency after supplementation was 80% in group 3 and it was significantly higher than in groups 1 (42%) and 2 (39%) (p = 0.03). The frequency of vitamin D sufficiency in the infants of the participants was 91% in group 3 and it was significantly higher than in groups 1 (36%) and 2 (52%) (p = 0.006). Conclusions: At least 2,000 IU/day of vitamin D is needed to ensure adequate vitamin D status in pregnancy and early infancy.

1.
Food and Nutrition Board, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes: Dietary Reference Intakes for Vitamin D and Calcium. Washington, National Academy Press, 2010.
2.
Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society: Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008;122:398-417.
3.
Judkins A, Eagleton C: Vitamin D deficiency in pregnant New Zealand women. NZ Med J 2006;119:U2144.
4.
Thandrayen K, Pettifor JM: Maternal vitamin D status: implications for the development of infantile nutritional rickets. Endocrinol Metab Clin North Am 2010;39:303-320.
5.
Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, Arden NK, Godfrey KM, Cooper C; Princess Anne Hospital Study Group: Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006;367:36-43.
6.
Dror DK: Vitamin D status during pregnancy: maternal, fetal, postnatal outcomes. Curr Opin Obstet Gynecol 2011;23:422-426.
7.
Miyake Y, Sasaki S, Tanaka K, Hirota Y: Dairy food, calcium and vitamin D intake in pregnancy and wheeze and eczema in infants. Eur Respir J 2010;35:1228-1234.
8.
Zipitis CS, Akobeng AK: Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008;93:512-517.
9.
Bassir M, Laborie S, Lapillonne A, Claris O, Chappuis MC, Salle BL: Vitamin D deficiency in Iranian mothers and their neonates: a pilot study. Acta Paediatr 2001;90:577-579.
10.
Ergur AT, Merih Berberoglu M, Atasay B, Isıklar Z, Bilir P, Arsan S, Söylemez F, Ocal G: Vitamin D deficiency in Turkish mothers and their neonates and in women of reproductive age. J Clin Res Ped Endo 2009;1:266-269.
11.
Alagöl F, Shihadeh Y, Boztepe H, Tanakol R, Yarman S, Azizlerli H, Sandalci O: Sunlight exposure and vitamin D deficiency in Turkish women. J Endocrinol Invest 2000;23:173-177.
12.
Andıran N, Yordam N, Özön A: The risk factors for vitamin D deficiency in breastfed newborns and their mothers. Nutrition 2002;18:47-50.
13.
Pehlivan İ, Hatun Ş, Aydoğan M, Babaoğlu K, Gökalp AS: Maternal vitamin D deficiency and vitamin D supplementation in healthy infants. Turk J Pediatr 2003;45:315-320.
14.
Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL: Vitamin D supplementation during pregnancy: double blind, randomized clinical trial of safety and effectiveness. Bone Miner Res 2011;26:2341-2357.
15.
Dawodu A, Saadi HF, Bekdache G, Javed Y, Altaye M, Hollis BW: Randomized controlled trial (RCT) of vitamin D supplementation in pregnancy in a population with endemic vitamin D deficiency. J Clin Endocrinol Metab 2013;98:2337-2346.
16.
OpenEpi: Open source epidemiologic statistics for public health. http://www.openepi.com.
17.
Pitkin RM: Endocrine regulation of calcium homeostasis during pregnancy. Clin Perinatol 1983;10:575-592.
18.
Food and Nutrition Board, Standing Committee on the Specific Evaluation of Dietary Reference Intakes: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, National Academy Press, 1997.
19.
Paunier L, Lacourt G, Pilloud P, Schlaeppi P, Sizonenko PC: 25-Hydroxyvitamin D and calcium levels in maternal, cord and infant serum in relation to maternal vitamin D intake. Helv Paediatr Acta 1978;33:95-103.
20.
Cockburn F, Belton NR, Purvis RJ, Giles MM, Brown JK, Turner TL, Wilkinson EM, Forfar JO, Barrie WJ, McKay GS, Pocock SJ: Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J 1980;231:1-10.
21.
Datta S, Alfaham M, Davies DP, Dunstan F, Woodhead S, Evans J, Richards B: Vitamin D deficiency in pregnant women from a non-European ethnic minority population: an interventional study. BJOG 2002;109:905-908.
22.
Hasanoğlu A, Özalp I, Özsoylu Ş: 25-Hydroxyvitamin D3 concentrations in maternal and cord blood at delivery. Çocuk Sağlığı ve Hastalıkları Dergisi 1981;24:207.
23.
Yesiltepe Mutlu G, Ozsu E, Oruc M, Cizmecioglu FM, Hatun S: Hypocalcemic seizure due to maternal vitamin D deficiency: how can it be prevented? Turk Pediatr J 2011;54:79-82.
24.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society: Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-1930.
25.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM: Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 2012;97:1153-1158.
26.
Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL: IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 2012;97:1146-1152.
27.
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:2987-2996.
28.
Hatun S, Islam O, Cizmecioglu F: Subclinical vitamin D deficiency is increased in adolescent girls who wear concealing clothing. J Nutr 2005;135:218-222.
29.
Mutlu A, Mutlu GY, Özsu E, Cizmecioğlu FM, Hatun Ş: Vitamin D deficiency in children and adolescents with type 1 diabetes. J Clin Res Pediatr Endocrinol 2011;3:179-183.
30.
Atiq M, Suria A: Maternal vitamin D deficiency in Pakistan. Acta Obstet Gynecol Scand 1998;77:970-973.
31.
Atiq M, Suria A, Nizami SQ: Vitamin D status of breast-fed Pakistani infants. Acta Paediatr 1998;87:737-740.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.